Rapalogix Health: Funding, Investors & Team (Oct 2026)

Rapalogix Health is a biotechnology company focused on developing longevity-based solutions for skin health and dermatological conditions. The company applies insights from longevity science and regenerative dermatology to address the underlying biological mechanisms of skin aging and disease, rather than focusing solely on cosmetic symptoms. Its research centers on regulating cellular pathways associated with aging, particularly mTOR/TORC1 signaling, with the goal of improving skin resilience, function, and long-term health. The company is developing a pipeline of therapeutic and skincare products based on its proprietary technology platform. Its lead technologies include RLX-201, a longevity-focused molecule used in professional skincare products, and RLX-202, a selective TORC1 inhibitor being developed for dermatological disorders. These programs are designed to restore cellular balance, support skin renewal, and address chronic skin conditions linked to dysregulated cellular aging processes. The company works with dermatologists, researchers, and healthcare professionals to translate advances in longevity science into clinical and commercial applications. Its activities span drug development, dermatology research, professional skincare, and skin longevity technologies, positioning the company at the intersection of biotechnology, dermatology, and healthy aging. In addition to therapeutics and skincare products, Rapalogix Health is developing skin health assessment technologies in collaboration with partners in artificial intelligence and molecular diagnostics. These tools are intended to measure skin function, biological age, and resilience, enabling more personalized approaches to skin health management and longevity-focused care.

Rapalogix Health has raised $20.0M across 1 round on record. The most recent is a Series A of $20.0M announced in Jun 2026.

Rapalogix Health's most recent funding round on record is a Series A of $20.0M, announced in Jun 2026.

FundedIQ lists Rahul Mehta (Founder) at Rapalogix Health.

Rapalogix Health is based in Carlsbad, California, United States.

Rapalogix Health is in the 1-10 employee band.

Rapalogix Health's latest round of $20.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.